Academic Journal

Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.

التفاصيل البيبلوغرافية
العنوان: Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.
المؤلفون: Schantl, A.E., Verhulst, A., Neven, E., Behets, G.J., D'Haese, P.C., Maillard, M., Mordasini, D., Phan, O., Burnier, M., Spaggiari, D., Decosterd, L.A., MacAskill, M.G., Alcaide-Corral, C.J., Tavares, AAS, Newby, D.E., Beindl, V.C., Maj, R., Labarre, A., Hegde, C., Castagner, B., Ivarsson, M.E., Leroux, J.C.
المصدر: Nature communications, vol. 11, no. 1, pp. 721
سنة النشر: 2020
المجموعة: Université de Lausanne (UNIL): Serval - Serveur académique lausannois
مصطلحات موضوعية: 6-Phytase/metabolism, Adenine/adverse effects, Animals, Cells, Cultured, Drug Evaluation, Preclinical/methods, Dynamic Light Scattering, Ethylene Glycol/chemistry, Humans, Injections, Subcutaneous, Inositol Phosphates/chemistry, Inositol Phosphates/pharmacokinetics, Inositol Phosphates/pharmacology, Male, Muscle, Smooth, Vascular/cytology, Vascular/drug effects, Rats, Sprague-Dawley, Uremia/drug therapy, Uremia/physiopathology, Vascular Calcification/chemically induced, Vascular Calcification/drug therapy, X-Ray Diffraction
الوصف: Myo-inositol hexakisphosphate (IP6) is a natural product known to inhibit vascular calcification (VC), but with limited potency and low plasma exposure following bolus administration. Here we report the design of a series of inositol phosphate analogs as crystallization inhibitors, among which 4,6-di-O-(methoxy-diethyleneglycol)-myo-inositol-1,2,3,5-tetrakis(phosphate), (OEG 2 ) 2 -IP4, displays increased in vitro activity, as well as more favorable pharmacokinetic and safety profiles than IP6 after subcutaneous injection. (OEG 2 ) 2 -IP4 potently stabilizes calciprotein particle (CPP) growth, consistently demonstrates low micromolar activity in different in vitro models of VC (i.e., human serum, primary cell cultures, and tissue explants), and largely abolishes the development of VC in rodent models, while not causing toxicity related to serum calcium chelation. The data suggest a mechanism of action independent of the etiology of VC, whereby (OEG 2 ) 2 -IP4 disrupts the nucleation and growth of pathological calcification.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/32024848; info:eu-repo/semantics/altIdentifier/eissn/2041-1723; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B322953EAB8C7; https://serval.unil.ch/notice/serval:BIB_B322953EAB8C; https://serval.unil.ch/resource/serval:BIB_B322953EAB8C.P001/REF.pdf
DOI: 10.1038/s41467-019-14091-4
الاتاحة: https://serval.unil.ch/notice/serval:BIB_B322953EAB8C
https://doi.org/10.1038/s41467-019-14091-4
https://serval.unil.ch/resource/serval:BIB_B322953EAB8C.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B322953EAB8C7
Rights: info:eu-repo/semantics/openAccess ; CC BY 4.0 ; https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.5A48C4AF
قاعدة البيانات: BASE
الوصف
DOI:10.1038/s41467-019-14091-4